Author/Authors :
Bertagna, Francesco Department of Nuclear Medicine - University of Brescia and Spedali Civili di Brescia - Brescia, Italy , Orlando, Emanuela Division of Radiology - Spedali Civili di Brescia - Brescia, Italy , Bertoli, Mattia Department of Nuclear Medicine - University of Brescia and Spedali Civili di Brescia - Brescia, Italy , Treglia, Giorgio Department of Nuclear Medicine / Center - Oncology Institute of Southern Switzerland - and PET CT Bellinzona, Switzerland
Abstract :
Screening for breast cancer has been realised as a
large-scale research in Europe and North America
with effective diagnostic and clinical results. The 1
obvious reason for performing and encouraging
screening is to reduce the incidence of mortality.
Breast screening has been demonstrated to prolong
lives; however, over-diagnosis is still a clinical
problem. Despite screening procedures, the 2
available data reporting incidental breast uptake,
revealed by F-18-fluoro-fluorodeoxygulose positron
emission tomography/computed tomography
(FDG-PET/CT) in patients studied for non
breastrelated oncologic purposes, suggest that some
lesions are still missed during traditional screening
work-up
